Global Autoimmune Disease Treatment Device Market Strategic Research Report

Scope of the Report

The global Autoimmune Disease Treatment Device market size is predicted to grow from US$ 10,031 million in 2025 to US$ 15,354 million in 2032; it is expected to grow at a CAGR of 6.5% from 2026 to 2032.

Autoimmune Disease Treatment Device refers to a category of medical devices designed to diagnose, manage, modulate, or therapeutically treat autoimmune disorders by regulating immune system activity, removing pathogenic substances from blood, delivering targeted stimulation, supporting biologic administration, or monitoring disease progression. These devices are used in the treatment of autoimmune conditions such as rheumatoid arthritis, lupus, multiple sclerosis, inflammatory bowel disease, psoriasis, myasthenia gravis, and type 1 diabetes. Autoimmune Disease Treatment Devices include plasmapheresis systems, immunoadsorption equipment, infusion pumps, neurostimulation devices, wearable monitoring systems, photopheresis systems, and targeted therapeutic delivery technologies that help improve disease management, reduce inflammatory activity, and enhance patient quality of life.

The Autoimmune Disease Treatment Device industry chain starts upstream with suppliers of medical-grade polymers, semiconductors, biosensors, filtration membranes, catheters, electronic components, biologic-compatible materials, and precision software systems, continues midstream through medical device manufacturers conducting product design, clinical testing, regulatory approval, intelligent system integration, assembly, sterilization, and distribution, and extends downstream to hospitals, specialty clinics, dialysis centers, research institutes, ambulatory care facilities, and homecare providers where devices are used for immune modulation, blood purification, biologic administration, disease monitoring, and long-term autoimmune disorder management, while service providers support maintenance, software upgrades, physician training, and post-treatment patient monitoring across global healthcare systems.

Current and planned projects in the Autoimmune Disease Treatment Device industry include expansion of blood purification device manufacturing facilities in North America and Europe, development of AI-enabled wearable immune monitoring platforms, establishment of advanced cleanroom assembly plants for biologic-compatible therapeutic devices, investment in smart neurostimulation technology production lines, construction of filtration membrane fabrication centers in Asia-Pacific, strategic partnerships between biotechnology companies and medical device manufacturers, localization of autoimmune treatment equipment manufacturing in emerging healthcare markets, modernization of robotic sterile assembly systems, development of remote patient management platforms, and large-scale R&D projects focused on personalized immune modulation technologies, minimally invasive treatment systems, digital therapeutics integration, and next-generation homecare autoimmune disease management solutions worldwide.

2025 Global Market Average Gross Profit Margin: 47%.

Global key Autoimmune Disease Treatment Device players cover Terumo Corporation, Fresenius Medical Care, Asahi Kasei Medical, Baxter, Therakos, etc.

This report presents a comprehensive overview of the global Autoimmune Disease Treatment Device market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Therapeutic Apheresis Devices
• Immunoadsorption Devices
• Extracorporeal Photopheresis (ECP) Systems
• Blood Purification Devices
• Cell Therapy / Immune Modulation Devices
• Neuromodulation Devices
• Others

Segment by Device Mobility

• Stationary Device
• Portable Device
• Wearable Device

Segment by Therapeutic Mechanism

• Blood Purification
• Immune Modulation
• Inflammation Suppression
• Neuromodulation
• Biologic Drug Administration
• Others

Segment by Application

• Systemic Autoimmune Diseases
• Gastrointestinal Autoimmune Disease
• Neurological Autoimmune Disorders
• Autoimmune Kidney Disease
• Dermatological Autoimmune Conditions

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Autoimmune Disease Treatment Device market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Systemic Autoimmune Diseases, Gastrointestinal Autoimmune Disease, Neurological Autoimmune Disorders evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact